Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease

NCT01766960 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Fatty Liver

Interventions

OTHER: High fat meal
DRUG: Morphine

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]